News

In the study, the company will assess tolerability, safety and phamacokinetics of BAL101553 to determine the dose and administration schedule for Phase II trials. Previosly, BAL101553, a novel

Allegro has devised a molecular testing platform that makes use of a genomic biomarker to detect early signs of lung cancer in current and former smokers. BronchoGen genomic

RISE and RIDE Phase III studies are double-masked, randomized, multicenter, sham injection-controlled, 36-month (sham injection-controlled for 24 months) and were intended to evaluate the efficacy and safety of

Relistor is indicated as a treatment for opioid-induced constipation (OIC) in patients with chronic, non-cancer pain. The drug is currently approved in the US, Australia, European Union, Canada

Under the agreement, AMRI will combine its discovery and development capabilities with Proteros’ structural biology services to offer better services to the life sciences industry worldwide. Proteros is

Out of all licensed products, some are the US Food and Drug Administration (FDA) approved drugs while rest are unapproved. As per the terms of the agreement, Atley

In the study, the companies have randomized around 679 patients who are suffering from early-stage Parkinson’s disease. The companies will assess the safety and efficacy of two dose

The double blinded, placebo-controlled, single center and randomized trial aims to establish the dosage level of the vaccine while assessing the immugenicity and safety of EV71. The company

As per the terms of the amended agreement, Meda will be responsible to pay a sum of $45m to Medivir for transferring of all rights to the product